Assessment of The Efficacy of Trastuzumab as Adjuvant Chemotherapy in Correlation with Clinicopathological Features in Patients with Her/2neu Positive Breast Cancer Attending Suez - Egyptian Knowledge Bank

33360

Assessment of The Efficacy of Trastuzumab as Adjuvant Chemotherapy in Correlation with Clinicopathological Features in Patients with Her/2neu Positive Breast Cancer Attending Suez

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGICAL DATA AND OUTCOMES OF HORMONAL POSITIVE HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAM

Article

Comparative Study between Results of Neo Adjuvant Chemotherapy and Upfront Surgery in Breast Cancer in Aswan Oncology Center: Cohert Study

Article

Clinico-Pathological Study of Prognostic Factors in HER-2 Positive Patients with Breast Cancer

Article

Frequency and Clinical Features of Over-Expressed HER2 in Egyptian Breast Cancer Women Patients

Article

The Impact of Trastuzumab Administration Patterns on the Long-Term Clinical Outcomes of Patients with Non-Metastatic Breast Cancer in a Resource-Limited Setting

Article

Assessment of Effectiveness of Maintenance Capecitabine among Triple Negative Breast Cancer Patients Attending Suez Canal University Hospital

Article

Efficacy and Safety of Lapatinib in Elderly Egyptian Patients with Her2 neu Positive Metastatic Breast Cancer

Article

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

Article

The Use of Trastuzumab in Metastatic Breast Cancer

Article

Letrozole and Anastrozole in Early Breast Cancer Post-menopausal Patients in Oncology Department at Suez Canal University Hospital